Anthocyanin as a therapeutic in Alzheimer's disease: A systematic review of preclinical evidences.
Systematic review · Ageing Res Rev · 2022. Source record refreshed; an explanation has not been reviewed.
About this paper
This page identifies the publication and its source. A checked explanation of its findings is not yet available.
Reading this record
Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.
Publication details
Anthocyanin as a therapeutic in Alzheimer's disease: A systematic review of preclinical evidences.
Suresh S, Begum RF, Singh S A et al.
Ageing Res Rev · 2022
- PubMed ID
- 35217244
- Record checked
A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.
Keep your place in the research.
Save this source or mark it as read.